MolPort, a global B2B marketplace, attracts late seed investment from FlyCap and Imprimatur Capital

Press Release

10th June 2015


MolPort, a Europe-based B2B e-commerce marketplace for R&D chemical compounds, has attracted a EUR 500K investment from VC funds FlyCap and Imprimatur Capital to fund international marketing and growth.

Several thousand companies worldwide manufacture millions of unique chemical compounds; however, because they are hard to find and buy, many of them remain unavailable to pharmaceutical and biotech researchers. For compound manufacturers marketing products is a complex and costly process, as potential customers are located all over the world and the market is large but highly fragmented.

MolPort has created a global chemical compound marketplace which enables buyers to find suppliers and thus help lab researchers greatly reduce the cost and time required for ordering chemicals for their pharmaceutical or biotech research needs. MolPort curated supplier network provides more than 25 million searchable chemical compounds, integrated with an easy-to-use, cost-effective, and centralized e-commerce ordering platform.

"We will use the investment money in marketing and strengthening of the sales team, as well as adding new features to the platform requested by our customers to ensure that MolPort can continue to satisfy the increasing demand and provide great customer service," said Dr Imants Zudans, CEO of MolPort.

MolPort customers include 9 of the top 10 world universities for chemistry, in addition to world-class research institutes, biotechnology and pharmaceutical companies from 65 countries.

Toby Moore, Managing Partner of Imprimatur Capital Fund Management, commented: "As an earlier investor in MolPort we are happy to also participate in this investment round because we continue to believe in the quality of the team and the global growth potential of the business."

FlyCap partner Janis Skutelis: "We invested in MolPort because it is already a global company, reaching customers in almost all corners of the world. MolPort has an efficient and energetic team, which is constantly working on improving its products. The company has a competitive position in the market."

In 2015 the market size of B2B e-commerce in the US alone reached USD 780 billion which is 9.3% of the entire B2B market. Forrester Research predicts that the e-commerce market will grow 8% per year over the next 5 years. The major segments for B2B e-commerce currently are oil products and the pharmaceutical industry.

KS "FlyCap Investment Fund I AIF" is a venture capital fund of EUR 10.5 million. FlyCap has already invested in such companies as AirDog, Mailigen, Bio2you, Cannelle, Arsenal Industrial, and RCG Lighthouse. The maximum investment of the fund in a company is EUR 1.5 million. FlyCap reviews investments in almost all sectors and development stages.

Imprimatur Capital, head-quartered in London, is a global technology seed investment firm. Riga-based Imprimatur Capital Fund Management to date has invested in 25 companies sourced from the Baltic, Nordic and Russia regions in such fields as nano-technology, green technology, electronics, e-commerce and SaaS software.

"Altum" is the main investor in the KS "FlyCap Investment Fund AIF". Since April 2015 the JSC "Development Finance Institution ALTUM" unites the Latvian Guarantee Agency, the Latvian Development Finance Institution ALTUM and the Rural Development Fund. "Altum" issues credit guarantees, provides mezzanine loans, and invests in venture capital funds.

ERDF granted the funds for "Altum" in the administration of "FlyCap".

2019 MolPort, v3.02, release date 07-06-2019 15:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.